Narcolepsy—clinical spectrum, aetiopathophysiology, diagnosis and treatment

CLA Bassetti, A Adamantidis, D Burdakov… - Nature Reviews …, 2019 - nature.com
Narcolepsy is a rare brain disorder that reflects a selective loss or dysfunction of orexin (also
known as hypocretin) neurons of the lateral hypothalamus. Narcolepsy type 1 (NT1) is …

Pathophysiology of migraine: a disorder of sensory processing

PJ Goadsby, PR Holland… - Physiological …, 2017 - journals.physiology.org
Plaguing humans for more than two millennia, manifest on every continent studied, and with
more than one billion patients having an attack in any year, migraine stands as the sixth …

[HTML][HTML] Oral orexin receptor 2 agonist in narcolepsy type 1

Y Dauvilliers, E Mignot, R del Río Villegas… - … England Journal of …, 2023 - Mass Medical Soc
Background Narcolepsy type 1 is caused by severe loss or lack of brain orexin
neuropeptides. Methods We conducted a phase 2, randomized, placebo-controlled trial of …

The immunopathogenesis of narcolepsy type 1

RS Liblau, D Latorre, BR Kornum… - Nature Reviews …, 2024 - nature.com
Abstract Narcolepsy type 1 (NT1) is a chronic sleep disorder resulting from the loss of a
small population of hypothalamic neurons that produce wake-promoting hypocretin (HCRT; …

International classification of sleep disorders

MJ Sateia - Chest, 2014 - Elsevier
The recently released third edition of the International Classification of Sleep Disorders
(ICSD) is a fully revised version of the American Academy of Sleep Medicine's manual of …

A genetically encoded sensor for in vivo imaging of orexin neuropeptides

L Duffet, S Kosar, M Panniello, B Viberti, E Bracey… - Nature …, 2022 - nature.com
Orexins (also called hypocretins) are hypothalamic neuropeptides that carry out essential
functions in the central nervous system; however, little is known about their release and …

[PDF][PDF] Sleep and sleep disorders 2 insomnia

ML Perlis, D Posner, D Riemann, CH Bastien, J Teel… - Lancet, 2022 - unmfm.pbworks.com
Insomnia is highly prevalent in clinical practice, occurring in up to 50% of primary care
patients. Insomnia can present independently or alongside other medical conditions or …

Orexin 2 receptor–selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients

R Evans, H Kimura, R Alexander… - Proceedings of the …, 2022 - National Acad Sciences
Narcolepsy type 1 (NT1) is a sleep disorder caused by a loss of orexinergic neurons.
Narcolepsy type 2 (NT2) is heterogeneous; affected individuals typically have normal orexin …

Epigenetic silencing of selected hypothalamic neuropeptides in narcolepsy with cataplexy

A Seifinejad, M Ramosaj, L Shan, S Li… - Proceedings of the …, 2023 - National Acad Sciences
Narcolepsy with cataplexy is a sleep disorder caused by deficiency in the hypothalamic
neuropeptide hypocretin/orexin (HCRT), unanimously believed to result from autoimmune …

Control of sleep and wakefulness

RE Brown, R Basheer, JT McKenna… - Physiological …, 2012 - journals.physiology.org
This review summarizes the brain mechanisms controlling sleep and wakefulness.
Wakefulness promoting systems cause low-voltage, fast activity in the …